In contrast, the oncogenic role of YY1 has been widely recognized across various cancer types [6, 16-19], though YY1 has been identified as a tumor suppressor in pancreatic cancer [39], breast cancer [40], and nasopharyngeal carcinoma [15]. Here, YY1 is linked to breast carcinoma.